Our Blog

Home
Blog Standard
Gene TherapyGenetic MedicineMuscular Dystrophy
January 27, 2026 Jesse Damsker Comments: 0

Gene Therapy Strategies for Muscular Dystrophies: Current Insights and Future Directions

This review article provides an in-depth overview of gene therapy modalities — including gene replacement, gene editing, and gene inactivation — and how these strategies are shaping the future of muscular dystrophy treatment....
Read More
CHKBCongenital Muscular DystrophyGenetics
January 27, 2026 Jesse Damsker Comments: 0

CHKB Splicing Research: Alternative Splicing Events of Rare CHKB Variants in MDCMC

New research has uncovered how rare CHKB variants disrupt RNA splicing, directly contributing to the pathology of megaconial congenital muscular dystrophy (MDCMC). These findings offer deeper insight into how CHKB deficiency leads to mitochondrial dysfunction and severe neuromuscular symptoms....
Read More
Clinical DevelopmentGene TherapyNeuromuscular Disease
January 27, 2026 Jesse Damsker Comments: 0

2024 MDA Summit Highlights Safety & Innovation in Gene Therapy

The 2024 Muscular Dystrophy Association Summit brought together international experts to discuss the scientific, operational, and ethical challenges of bringing gene therapies safely to patients. The meeting marks a major milestone in accelerating progress for neuromuscular diseases....
Read More
AAVGene TherapyMuscular Dystrophy
January 27, 2026 Jesse Damsker Comments: 0

Toward an AAV Gene Therapy to Treat Muscular Dystrophies

New innovations in AAV vector engineering — including dual-vector methods and enhanced tissue targeting — are opening doors for treating muscular dystrophies once considered untreatable....
Read More
CardiomyopathyCase ReportCHKB
January 25, 2026 Jesse Damsker Comments: 0

A Rare Homozygous Variant of CHKB Induced Severe Dilated Cardiomyopathy

The 2024 Muscular Dystrophy Association Summit brought together international experts to discuss the scientific, operational, and ethical challenges of bringing gene therapies safely to patients. The meeting marks a major milestone in accelerating progress for neuromuscular diseases....
Read More